NeuroXess

Series-B
neuroxess.com Biotech & Healthcare Shanghai
Total Funding $105.0M
Latest Round $105M Series-B
Last Announced Oct 28, 2026
Investors 13 Backers
Decision Makers 2 Available

About NeuroXess

NeuroXess develops brain-computer interface technologies and solutions for scientific research and medical applications.

Sectors & Market Categories

Company Details

Intelligence Dossier

Corporate & Operational Profile

Primary Industry Biotech & Healthcare
Funding Stage Series-B
Global Headquarters Shanghai
Tracked Since Oct 28, 2026

Web & Domain Identity

Official Website neuroxess.com
Domain Registered Date Undisclosed

Social & Network Presence

X / Twitter Profile @_NeuroXess
LinkedIn Corporate Company Profile

Company Milestones & Timeline

1 Events
  1. Capital Raise

    Raised $105,010,000 · Series-B

    Backed by SDIC Unity Capital

Investors & Backers

13
SDIC Unity Capital
Lead
China Fortune-Tech Capital
Huangpu Biomedicine Industry Investment Fund Management
Huasai Zhihui Private Equity Fund Management
IDG Capital
Jiangxi Financial Holdings
Junxi Capital
Shanda Group
Shenzhen Capital Group
TriWise Capital
Xichen Capital
Zhongping Capital
ZWC Partners

Funding History

1 Round
Series-B equity · Oct 28, 2026

Round backers: SDIC Unity Capital

$105,010,000 eu.36kr.com

Founders & Leadership

2

Peng Lei

Founder

Work email & phone locked Unlock →

Tao Hu

Founder

Work email & phone locked Unlock →

Press Coverage & Sources

Recently Funded Biotech & Healthcare Startups

View all

Search the startup feeds free with 50 starter credits.

Recently funded startups
New SaaS launches
Never pay twice for contacts